Murugan Amar's Form 4 filing
Atara Biotherapeutics, Inc.ATRA · filed Aug 20, 2024
- Accession no.
- 0000905148-24-002304
- Filed
- Aug 20, 2024
- Trade date
- Aug 16, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $7.68K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murugan AmarCIK 0001809916 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | Common Stock | SSaleDisposed | −877 | $6.63F2 | −$5,814.51 | 27,108 | Direct | |
| Aug 16, 2024 | Common Stock | SSaleDisposed | −192 | $6.63F2 | −$1,272.96 | 26,916 | Direct | |
| Aug 16, 2024 | Common Stock | SSaleDisposed | −89 | $6.63F2 | −$590.07 | 26,827 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Referenced by the price of 3 transactions in Table I.